SCHEMBL3668702

SCHEMBL3668702

CNC(=O)Oc1cc(C)c2nnc(N)n2n1

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 1/20 0.31
MAPT P10636 1/20 0.30
HTT P42858 1/20 0.30
BCHE P06276 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3670148 0.86 KMT2A (0.35) MAPT
SCHEMBL16493948 0.85 MAPT (0.31) MAPTHTT
Hydrochloric Acid SCHEMBL3665460 0.83 MAPT (0.32) MAPTHTT
SCHEMBL1204332 0.76 BAZ2B (0.46) MAPT
SCHEMBL1205982 0.74 KDM4E (0.39) MAPT
SCHEMBL10204128 0.71 RXFP1 (0.38)
SCHEMBL9907111 0.70
Hydrochloric Acid SCHEMBL1205708 0.70 RXFP1 (0.37)
Bromide SCHEMBL1187591 0.68 MEN1 (0.32) MAPT
Trifluoroacetic Acid SCHEMBL1188369 0.68 ALDH1A1 (0.33) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2240487-B1 TRIAZOLOPYRIDAZINES AS PAR1 INHIBITORS, PRODUCTION THEREOF, AND USE AS MEDICAMENTS SANOFI SA (FR) 2011-12-14 EP disclosed
EP-2240487-A1 TRIAZOLOPYRIDAZINES AS PAR1 INHIBITORS, PRODUCTION THEREOF, AND USE AS MEDICAMENTS Sanofi-Aventis (FR) 2010-10-20 EP disclosed
WO-2009097970-A1 TRIAZOLOPYRIDAZINES AS PAR1 INHIBITORS, PRODUCTION THEREOF, AND USE AS MEDICAMENTS SANOFI-AVENTIS (FR) 2009-08-13 WO disclosed